CARMIEL, Israel, March 16, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), announced today that its board of directors has set May 5, 2012, as the record date for shareholders entitled to receive notice of, and to vote at, the Company’s 2012 Annual Meeting of Shareholders. It is currently anticipated that the Company’s 2012 Annual Meeting of Shareholders will be held on or around June 25, 2012, in Tel Aviv, Israel. The final date and location of the meeting will be announced in the proxy statement to be filed and distributed by the Company in connection with the meeting.
